Cargando…

Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance

SIMPLE SUMMARY: Glioblastoma is among the most lethal cancers in humans. Glioblastomas exhibit a striking heterogeneity, which is maintained by a highly plastic, adaptable population of glioma stem cells (GSCs). Glioblastomas inevitably recur as therapy-resilient tumors, and accumulating evidence in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eckerdt, Frank, Platanias, Leonidas C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340782/ https://www.ncbi.nlm.nih.gov/pubmed/37444568 http://dx.doi.org/10.3390/cancers15133458

Ejemplares similares

Combined PI3Kα-mTOR Targeting of Glioma Stem Cells
por: Eckerdt, Frank D., et al.
Publicado: (2020)

Targeting of glioblastoma cell lines and glioma stem cells by combined PIM kinase and PI3K-p110α inhibition
por: Iqbal, Asneha, et al.
Publicado: (2016)

Antineoplastic effects of selective CDK9 inhibition with atuveciclib on cancer stem-like cells in triple-negative breast cancer
por: Brisard, Daphne, et al.
Publicado: (2018)

HDL nanoparticles targeting sonic hedgehog subtype medulloblastoma
por: Bell, Jonathan B., et al.
Publicado: (2018)

Pharmacological mTOR targeting enhances the antineoplastic effects of selective PI3Kα inhibition in medulloblastoma
por: Eckerdt, Frank, et al.
Publicado: (2019)

Regulatory effects of a Mnk2-eIF4E feedback loop during mTORC1 targeting of human medulloblastoma cells
por: Eckerdt, Frank, et al.
Publicado: (2014)

Regulation of IFNα-induced expression of the short ACE2 isoform by ULK1
por: Perez, Ricardo E., et al.
Publicado: (2022)

Innate Immune Mechanisms and Immunotherapy of Myeloid Malignancies
por: Small, Sara, et al.
Publicado: (2021)

Role of Biomarkers in the Management of Acute Myeloid Leukemia
por: Small, Sara, et al.
Publicado: (2022)

Treatment Resistance Mechanisms of Malignant Glioma Tumor Stem Cells
por: Schmalz, Philip G.R., et al.
Publicado: (2011)

Deregulation of Interferon Signaling in Malignant Cells
por: Katsoulidis, Efstratios, et al.
Publicado: (2010)

Human SLFN5 is a Transcriptional Co-repressor of STAT1-Mediated Interferon Responses and Promotes the Malignant Phenotype in Glioblastoma
por: Arslan, Ahmet Dirim, et al.
Publicado: (2017)

A novel approach to overcome drug resistance in acute myeloid leukemia
por: Mazewski, Candice, et al.
Publicado: (2023)

MNK Proteins as Therapeutic Targets in Leukemia
por: Mazewski, Candice, et al.
Publicado: (2023)

Emerging Role of Cellular Prion Protein in the Maintenance and Expansion of Glioma Stem Cells †
por: Thellung, Stefano, et al.
Publicado: (2019)

Antiangiogenic Therapy and Mechanisms of Tumor Resistance in Malignant Glioma
por: Rahman, Ruman, et al.
Publicado: (2010)

Type I and II Interferons in the Anti-Tumor Immune Response
por: Fenton, Sarah E., et al.
Publicado: (2021)

Glioma Stem Cells: Signaling, Microenvironment, and Therapy
por: Liebelt, Brandon D., et al.
Publicado: (2016)

Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells
por: Saleiro, Diana, et al.
Publicado: (2023)

AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications
por: Vakana, Eliza, et al.
Publicado: (2011)

ULK1 in type I interferon response
por: Saleiro, Diana, et al.
Publicado: (2015)

The emerging role of miR‐19 in glioma
por: Wang, Weihan, et al.
Publicado: (2018)

The role of stem cells in tumor targeting and growth suppression of gliomas
por: Eskandary, Hossein, et al.
Publicado: (2011)

Glioma stem cells and their roles within the hypoxic tumor microenvironment
por: Boyd, Nathaniel H., et al.
Publicado: (2021)

Mechanisms of Anticancer Therapy Resistance: The Role of Cancer Stem Cells
por: Kazi, Julhash U.
Publicado: (2020)

Emerging roles of Myc in stem cell biology and novel tumor therapies
por: Yoshida, Go J.
Publicado: (2018)

Mechanism of RIP2 enhancing stemness of glioma cells induces temozolomide resistance
por: Wang, Xiao‐liang, et al.
Publicado: (2022)

The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma
por: Das, Plabon Kumar, et al.
Publicado: (2020)

Emerging Roles and Therapeutic Interventions of Aerobic Glycolysis in Glioma
por: Han, Wei, et al.
Publicado: (2020)

Emerging Roles of TRIM Family Proteins in Gliomas Pathogenesis
por: Giannopoulou, Angeliki-Ioanna, et al.
Publicado: (2022)

Glioma Stem Cells and Immunotherapy for the Treatment of Malignant Gliomas
por: Toda, Masahiro
Publicado: (2013)

Emerging roles of mesenchymal stem cell therapy in patients with critical limb ischemia
por: Shirbaghaee, Zeinab, et al.
Publicado: (2022)

Inhibitory effects of SEL201 in acute myeloid leukemia
por: Kosciuczuk, Ewa M., et al.
Publicado: (2019)

Emerging candidates in breast cancer stem cell maintenance, therapy resistance and relapse
por: Sharma, Bhawna, et al.
Publicado: (2011)

Emerging mechanisms of asymmetric stem cell division
por: Venkei, Zsolt G., et al.
Publicado: (2018)

An aberrantly sustained emergency granulopoiesis response accelerates postchemotherapy relapse in MLL1-rearranged acute myeloid leukemia in mice
por: Wang, Hao, et al.
Publicado: (2020)

Current and Emerging Therapies for Limbal Stem Cell Deficiency
por: Elhusseiny, Abdelrahman M, et al.
Publicado: (2022)

Pathophysiological roles of integrins in gliomas from the perspective of glioma stem cells
por: Wang, Maoyu, et al.
Publicado: (2022)

Emerging roles of ferroptosis in glioma
por: Shi, Jiaqi, et al.
Publicado: (2022)

Nanoparticles for Stem Cell Therapy Bioengineering in Glioma
por: Ruiz-Garcia, Henry, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7acbo282irnqa507mjvdv4n2ni